Literature DB >> 24000280

St. Gallen 2013: brief preliminary summary of the consensus discussion.

Nadia Harbeck1, Christoph Thomssen, Michael Gnant.   

Abstract

The 2013 St. Gallen Consensus Conference on early breast cancer provided mostly evidence-based, globally valid treatment recommendations for breast cancer care, with a broad spectrum of acceptable clinical practice. This report summarizes the results of the 2013 international panel voting procedures with regard to loco-regional and endocrine treatment, chemotherapy, targeted therapy as well as adjuvant bisphosphonate use. This report is not aimed to replace the official St. Gallen Consensus publication, some recommendations may even be altered in the final paper, but should serve a preliminary rapid report of this important meeting.

Entities:  

Keywords:  Axillary dissection; Bisphosphonates; Chemotherapy; Early breast cancer; Endocrine therapy; Neoadjuvant therapy; Surgery; Targeted therapy

Year:  2013        PMID: 24000280      PMCID: PMC3683952          DOI: 10.1159/000351193

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  6 in total

1.  Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast & Colorectal Cancer Study Group.

Authors:  Raimund Jakesz; Hellmut Samonigg; Michael Gnant; Ernst Kubista; Dieter Depisch; Roland Kolb; Brigitte Mlineritsch; Hans-Jörg Mischinger; Rainer-Christian Menzel; Peter Steindorfer; Werner Kwasny; Christoph Tausch; Michael Stierer; Susanne Taucher; Michael Seifert; Hubert Hausmaninger
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

2.  Results of the First Austrian Multidisciplinary Expert Panel on Controversies in Local Treatment of Breast Cancer.

Authors:  Michael Knauer; Michael Gnant; Florian Fitzal
Journal:  Breast Care (Basel)       Date:  2012-02-20       Impact factor: 2.860

3.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

4.  Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.

Authors:  Armando E Giuliano; Kelly K Hunt; Karla V Ballman; Peter D Beitsch; Pat W Whitworth; Peter W Blumencranz; A Marilyn Leitch; Sukamal Saha; Linda M McCall; Monica Morrow
Journal:  JAMA       Date:  2011-02-09       Impact factor: 56.272

5.  Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011.

Authors:  A Goldhirsch; W C Wood; A S Coates; R D Gelber; B Thürlimann; H-J Senn
Journal:  Ann Oncol       Date:  2011-06-27       Impact factor: 32.976

6.  Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009.

Authors:  A Goldhirsch; J N Ingle; R D Gelber; A S Coates; B Thürlimann; H-J Senn
Journal:  Ann Oncol       Date:  2009-06-17       Impact factor: 32.976

  6 in total
  48 in total

1.  Is sentinel lymph node biopsy enough for axillary macrometastasis?

Authors:  Merdan Fayda; Makbule Tambaş; Hasan Karanlık
Journal:  Ulus Cerrahi Derg       Date:  2015-12-01

2.  Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies.

Authors:  J Gagnon; E Lévesque; F Borduas; J Chiquette; C Diorio; N Duchesne; M Dumais; L Eloy; W Foulkes; N Gervais; L Lalonde; B L'Espérance; S Meterissian; L Provencher; J Richard; C Savard; I Trop; N Wong; B M Knoppers; J Simard
Journal:  Curr Oncol       Date:  2016-12-21       Impact factor: 3.677

3.  Guidelines: usefulness and limitations.

Authors:  Michael Gnant
Journal:  Breast Care (Basel)       Date:  2013-06       Impact factor: 2.860

4.  Clinicopathological relevance of kinesin family member 18A expression in invasive breast cancer.

Authors:  Mai Kasahara; Makoto Nagahara; Tsuyoshi Nakagawa; Toshiaki Ishikawa; Takanobu Sato; Hiroyuki Uetake; Kenichi Sugihara
Journal:  Oncol Lett       Date:  2016-07-07       Impact factor: 2.967

5.  Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.

Authors:  Linnea Langhans; Maj-Britt Jensen; Maj-Lis M Talman; Ilse Vejborg; Niels Kroman; Tove F Tvedskov
Journal:  JAMA Surg       Date:  2017-04-01       Impact factor: 14.766

6.  Indian Solutions for Indian Problems-Association of Breast Surgeons of India (ABSI) Practical Consensus Statement, Recommendations, and Guidelines for the Treatment of Breast Cancer in India.

Authors:  S P Somashekhar; Gaurav Agarwal; S V S Deo; P Raghu Ram; Diptendra Sarkar; Vani Parmar
Journal:  Indian J Surg       Date:  2017-06-22       Impact factor: 0.656

Review 7.  Main controversies in breast cancer.

Authors:  Stephane Zervoudis; George Iatrakis; Eirini Tomara; Anastasia Bothou; George Papadopoulos; George Tsakiris
Journal:  World J Clin Oncol       Date:  2014-08-10

Review 8.  Significance of immunohistochemistry in breast cancer.

Authors:  Dana Carmen Zaha
Journal:  World J Clin Oncol       Date:  2014-08-10

9.  Associations between sociodemographic and clinicopathological factors and breast cancer subtypes in a population-based study.

Authors:  Adana A M Llanos; Sheenu Chandwani; Elisa V Bandera; Kim M Hirshfield; Yong Lin; Christine B Ambrosone; Kitaw Demissie
Journal:  Cancer Causes Control       Date:  2015-09-16       Impact factor: 2.506

10.  Disease evolution and heterogeneity in bilateral breast cancer.

Authors:  Elena Fountzilas; Vassiliki Kotoula; Flora Zagouri; Eleni Giannoulatou; George Kouvatseas; George Pentheroudakis; Triantafyllia Koletsa; Mattheos Bobos; Kyriaki Papadopoulou; Epaminontas Samantas; Efterpi Demiri; Spyros Miliaras; Christos Christodoulou; Sofia Chrisafi; Evangelia Razis; Florentia Fostira; Dimitrios Pectasides; George Zografos; George Fountzilas
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.